Overview of major salivary gland cancer surgery in Ontario (2003–2010)

Journal of Otolaryngology-Head & Neck Surgery

David P Goldstein⁶  David R Urbach⁴  Stephen F Hall³  Patti A Groome⁷  Ralph Gilbert¹  Patrick Gullane¹  Jeremy Freeman⁵  Jonathan Irish¹  Antoine Eskander² 

[1] Department of Otolaryngology – Head and Neck Surgery, Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada;Department of Otolaryngology – Head and Neck Surgery, University of Toronto, Toronto, ON, Canada;Department of Otolaryngology – Head and Neck Surgery, Queen’s University, Kingston, ON, Canada;Division of General Surgery, Department of General Surgery and Surgical Oncology, University of Toronto, Toronto, ON, Canada;Department of Otolaryngology – Head and Neck Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada;Department of Otolaryngology – Head & Neck Surgery, University Health Network, Princess Margaret Hospital, 610 University Ave., Rm 3-952, Toronto M5G 2M9, ON, Canada;Cancer Care and Epidemiology Division, Queen’s Cancer Research Institute, Queen’s University, Kingston, ON, Canada

关键词: Head and neck oncology;    Salivary gland cancer;    Health policy;    Health services research;   

Others  :  1133152
DOI  :  10.1186/s40463-014-0050-6

 received in 2014-07-15, accepted in 2014-11-25,  发布年份 2014

【 摘 要 】

Background

The primary objective of this study is to describe variations in incidence rates, resection rates, and types of surgical ablations performed on patients diagnosed with major salivary gland cancers in Ontario.

Methods

All major salivary gland cancer cases in Ontario (2003–2010) were identified from the Ontario Cancer Registry (n = 1,241). Variations in incidence rates, resection rates, and type of surgical therapy were compared by sex, age group, neighbourhood income, community population, health region, and physician specialty.

Results

Eight-year incidence rates per 100,000 vary significantly by sex (male: 15.5, female: 9.7), age (18–54 years: 6.7, 75+ years: 53.4), neighborhood income (lowest quintile: 11.8, highest quintile: 13.7), and community size (cities with a population greater than 1.5 million: 10.6, cities with a population of less than 100,000: 14.7). There was a significant correlation between the likelihood to receive a resection and age with the elderly (75+ years) being the least likely to receive resection (69%). Large differences in incidence and resection rates were observed by health region. Otolaryngology-Head & Neck surgeons provide the majority of total/radical resections (95%).

Conclusions

Major salivary gland cancer incidence rates vary by sex, age, neighborhood income, community size, and health region. Resection rates vary by age and health region. These disparities warrant further evaluation. Otolaryngology-Head & Neck Surgeons provide the majority of major salivary gland cancer surgical care.

【 授权许可】

   
2014 Eskander et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Canadian cancer statistics [Internet]. Toronto, ON: Canadian Cancer Society; 2013. [updated May, 2013; cited March 15, 2014]. Available from: http://www.cancer.ca/en/en/cancer-information/cancer-type/salivary-gland/statistics/?region=ns.
• [2]Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP: Trends in incidence and prognosis for head and neck cancer in the united states: a site-specific analysis of the SEER database. Int J Cancer 2005, 114(5):806-1.
• [3]Davies L, Welch HG: Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 2006, 135(3):451-457.
• [4]Boukheris H, Curtis RE, Land CE, Dores GM: Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev 2009, 18(11):2899-2906.
• [5]Speight PM, Barrett AW: Salivary gland tumours. Oral Dis 2002, 8(5):229-240.
• [6]Iscoe NA, To T, Gort EH, Tran M: Cancer Surgery in Ontario. Institute for Clinical Evaluative Sciences, Toronto; 1997.
• [7]McLaughlin JR, Kreiger N, Marrett LD, Holowaty EJ: Cancer incidence registration and trends in ontario. Eur J Cancer 1991, 27(11):1520-1524.
• [8]Hall S, Schulze K, Groome P, Mackillop W, Holowaty E: Using cancer registry data for survival studies: the example of the Ontario cancer registry. J Clin Epidemiol 2006, 59(1):67-76.
• [9]Urbach DR, Simunovic M, Schultz SE: Cancer Surgery in Ontario: ICES Atlas. Institute for Clinical Evaluative Sciences, Toronto; 2008.
• [10]Genther DJ, Gourin CG: The effect of comorbidity on short-term outcomes and cost of care after head and neck cancer surgery in the elderly. Head Neck 2014. doi: 10.1002/hed.23651. [Epub ahead of print]
• [11]Chen MM, Roman SA, Sosa JA, Judson BL. Prognostic factors for squamous cell cancer of the parotid gland: An analysis of 2,104 patients. Head Neck 2013. doi: 10.1002/hed.23566. [Epub ahead of print]
• [12]Bradley PJ, McGurk M: Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg 2013, 51(5):399-403.
• [13]Hwang E, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M: Incidence of head and neck cancer and socioeconomic status in canada from 1992 to 2007. Oral Oncol 2013, 49(11):1072-1076.
• [14]Ellis GL, Auclair PL: Tumors of the Salivary Glands. 3rd ed. Armed Forces Institute of Pathology, Editor. Atlas of Tumor Pathology, Washington, DC; 1996.
• [15]Lönn S, Ahlbom A, Christensen HC, Johansen C, Schüz J, Edström S, Henriksson G, Lundgren J, Wennerberg J, Feychting M: Mobile phone use and risk of parotid gland tumor. Am J Epidemiol 2006, 164(7):637-643.
• [16]Schuz J, Jacobsen R, Olsen JH, Boice JD Jr, McLaughlin JK, Johansen C: Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst 2006, 98(23):1707-1713.
• [17]Eskander A, Merdad M, Irish JC, Hall SF, Groome PA, Freeman JL, Urbach DR, Goldstein DP: Volume-outcome associations in head and neck cancer treatment: a systematic review and meta-analysis. Head Neck 2013, 36(12):1820-34.